SAMANTHA SALVATORA: Open Payments
NPI 1144765256 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,182 in 92 payments from 15 companies in 2025. Trend: 2023 $6,460 · 2024 $12,495 · 2025 $23,182
Speaker / faculty: $15,540Travel & lodging: $4,272Food & beverage: $2,922Consulting: $275Education: $173
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 29 | $19,250 |
| Incyte Corporation | 12 | $2,078 |
| Astellas Pharma US Inc | 8 | $364 |
| Novartis Pharmaceuticals Corporation | 13 | $358 |
| ABBVIE INC. | 4 | $354 |
| Celgene Corporation | 8 | $203 |
| Lilly USA, LLC | 3 | $162 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Geron Corporation | 2 | $72 |
| GlaxoSmithKline, LLC. | 3 | $67 |
Products named: JAKAFI, REVUFORJ, SCEMBLIX, VENCLEXTA, REBLOZYL, JAYPIRCA, Cresemba, CALQUENCE.
Industry payments across TX — which companies pay providers there.
